Currently out of the existing stock ratings of Thomas Stephan, 13 are a HOLD (35.14%), 24 are a BUY (64.86%).

Thomas Stephan

Work Performance Price Targets & Ratings Chart

Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 68.24% that have a potential upside of 13.58% achieved within 64 days.

Thomas Stephan’s has documented 74 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on STAA, STAAR Surgical Company at 12-Feb-2025.

Wall Street Analyst Thomas Stephan

Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 12/8/2022. The price target of $60 was fulfilled within 1 day with a profit of $2.6 (4.15%) receiving and performance score of 41.53.

Average potential price target upside

GKOS Glaukos Corp SGHT Sight Sciences STAA STAAR Surgical Company RXST Rxsight ALC Alcon AG BLCO Bausch + Lomb Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$176

$50.12 (39.82%)

$137

1 days ago
(21-Feb-2025)

12/13 (92.31%)

$50.12 (39.82%)

110

Hold

$200

$74.12 (58.88%)

$115

3 days ago
(19-Feb-2025)

8/9 (88.89%)

$47.04 (30.75%)

70

Buy

$180

$54.12 (42.99%)

$140

26 days ago
(27-Jan-2025)

38/39 (97.44%)

$22.97 (14.63%)

128

Buy

$175

$49.12 (39.02%)

$153

1 months 22 days ago
(31-Dec-2024)

7/8 (87.5%)

$25.06 (16.71%)

97

Buy

$185

$59.12 (46.97%)

$152

2 months 4 days ago
(18-Dec-2024)

2/3 (66.67%)

$39.86 (27.46%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Thomas Stephan is most bullish on?

Potential upside of $49.12 has been obtained for GKOS (GLAUKOS CORP)

Which stock is Thomas Stephan is most reserved on?

Potential downside of $2.25 has been obtained for BLCO (BAUSCH + LOMB CORP)

What Year was the first public recommendation made by Thomas Stephan?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?